The loss of CDKN2A, which encodes p16, by either gene deletion, promoter hypermethylation, or mutation, found in 16% of RCC, correlated with poor survival in ccRCC, PRCC, and ChRCC. This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.